Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

News Briefs

Pharmaceutical Giants Offer More AIDS Drugs and Medical Services in China

April 22, 2003

Several multinational drug makers, including GlaxoSmithKline and Merck Sharp and Dohme, are set to provide more AIDS prevention and treatment services in China. About 1 million HIV patients have been registered in China, according to the Ministry of Health, and the Chinese government has accelerated the nationalization of HIV/AIDS drug production capacity. It has also negotiated with international pharmaceutical companies in an effort to secure AIDS drugs at lower prices. MSD has cooperated with the government in medical training and public education programs on preventing HIV/AIDS. "Only a comprehensive prevention and treatment plan, funded at least partially by the government, along with the improvement of fundamental medical infrastructure and proper medical training, can control the epidemic situation," said Qu Wanwan, chief inspector of the marketing department of MSD China.

Back to other CDC news for April 22, 2003

Previous Updates

Adapted from:
Xinhua News Agency
04.21.03


  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
More on Generic/Discount HIV Drug Access in the Developing World
Advertisement:
Find out how a Walgreens specially trained pharmacist can help you

Tools
 

Advertisement